A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor

NCT04254939 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: CS3007 (BLU-285)

Sponsor

CStone Pharmaceuticals

Collaborators

[object Object]